Consensus WELL Health Technologies Corp.

Equities

WELL

CA94947L1022

Market Closed - Toronto S.E. Other stock markets 04:00:00 2024-04-26 pm EDT			5-day change	1st Jan Change
3.59 ^CAD	+0.28%		+1.99%	-6.75%

Apr. 18	WELL Health Maintained at Buy at Stifel GMP as it Buys 10 Clinics From Shoppers Drug Mart; Price Target Kept at C$11.00	MT
Apr. 17	WELL Health Technologies Rises 3%, TD Says Shopper Drug Mart Deal Likely For "Low Price"	MT

Evolution of the average Target Price on WELL Health Technologies Corp.

Price target over the last 5 years

History of analyst recommendation changes

0d9bd401b1c85b9b547.UsoO8YC8HCeSrCauD8GWBkwI2WbHtj8d1X3IjulMF6A.JJNtkrjSX0Dkx2DiNqTGQhRMvjO13kltmT7676V7cegw52-D-t9zU_abaw~c919826bee518934a5fe7a925b3350eb

Analyst Recommendations on WELL Health Technologies Corp.

WELL Health Maintained at Buy at Stifel GMP as it Buys 10 Clinics From Shoppers Drug Mart; Price Target Kept at C$11.00	Apr. 18	MT
WELL Health Technologies Rises 3%, TD Says Shopper Drug Mart Deal Likely For "Low Price"	Apr. 17	MT
WELL Health Technologies Initiated at Outperform, $5.50 Price Target at RBC	Feb. 06	MT
Well Health Brief: Says Achieved record quarterly revenues of $204.5 million; Raises Guidance for Balance of 2023 and Provides Guidance of Over $900 Million in Revenue for 2024	Nov. 14	MT
WELL Health Technologies Maintained at Buy at Stifel GMP Following Clinic Acquisitions; Price Target Kept at C$13.50	23-05-23	MT
WELL Health Technologies Initiated at Outperform, $8.50 Price Target at Raymond James	23-04-25	MT
WELL Health Technologies Buy Rating Reiterated at Stifel GMP Following Good Q4 Results; Price Target Kept at C$13.50	23-03-22	MT
WELL Health Reports Record Revenue and Adjusted EBITDA Results for Q3-2022 and Raises Guidance for Fourth Straight Quarter	22-11-10	PR
WELL Health Technologies : Reports Record Revenue and Adjusted EBITDA Results for Q3-2022 and Raises Guidance for Fourth Straight Quarter	22-11-10	PU
WELL Health Reports Record Quarterly Revenue and Adjusted EBITDA in Q2-2022 and Raises Guidance for 3rd Straight Quarter	22-08-11	AQ
WELL Health Technologies Buy Rating Kept at Stifel GMP as Credit Facility Expanded	22-07-19	MT
WELL Health Technologies Kept at Buy at Stifel GMP Following Formation of a Canadian Clinic Unit	22-07-15	MT
Scotiabank's Take on Well Health's INLIV Acquisition	22-06-21	MT
Scotiabank Maintains Outperform, $9 TP on Well Health After Company Releases Prelim Q1 Results	22-04-26	MT
GUIDANCE: (WELL.TO) WELL HEALTH TECHNOLOGIES Adds This "Catapults" Its Estimated Proforma Annualized Revs Run Rate to Almost $400 Million with Adjusted EBITDA Run Rate Approaching $100 Million	21-08-12	MT
Well Health Brief: In initiating Coverage, Scotia Analyst Adam Buckham Set a TP of $10.00/share and a 25.2% Rate of Return on Shares Within Next 12 Months, While Opening with a Sector Perform Rating, Cantech has noted	21-07-20	MT
Well Health Brief: Scotiabank Has Sector Perform and $10 Price Target on It Vs Mostly Buy Ratings and Average PT on Bay Street of More Than $11.50, notes BNN TV	21-07-19	MT
WELL HEALTH TECHNOLOGIES : Target Price Increased to $11 at TD, Analyst Sees More Acquisitions	21-06-08	MT
WELL HEALTH TECHNOLOGIES : Rises More than 5%, TD Says MyHealth Acquisition Likely To Be Viewed "Positively"	21-06-07	MT
WELL HEALTH TECHNOLOGIES : Upgraded to Buy After Intrahealth Acquisition	21-03-09	MT
Well Health Brief: Cut To Hold With Target Price of $10.50 at Desjardins On Run Up In Shares (+12%) Following CRH Deal, says BNN Bloomberg TV	21-02-09	MT
Well Health CRH Medical Corporation Webcast Brief: CEO Shahbazi Says CIBC and HSBC Debt Facility Rates Are Between 1.5% and 3.25%	21-02-08	MT